entertainment -WSS

entertainment

author：leisure time 2025-09-30 16:28:27 - browse：2829

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Inside the rise of 'mukbang' eating videos

WSS

A public health expert passes on football's full body collisions for youths

Biden administration plans revamp of organ transplant system

Patients, doctors are clashing about side effects of hormonal birth control

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Senate panel passes drug pricing bills, but drops one PBM reform

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

entertainment

entertainment

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Reanimated hearts work just as well for transplants, study finds

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cord blood banking comes at a high cost to babies

Duchenne breakthrough therapy leaves behind pioneering families

The Pandemic Treaty must support building strong health systems

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Mom launches Girl Scout troop for LGBTQ youth in Texas

Trump demands the U.S. pay no more for drugs than other countries … again

At ASCO, AstraZeneca reports strong data for breast cancer drug

Wikipedia

At ASCO, AstraZeneca reports strong data for breast cancer drug

How to fix the rural physician shortage in the U.S.

Ionis drug prevents swelling attacks due to hereditary angioedema

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Sea level rise could wash away turtle breeding grounds around the world, researchers say

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

hotspot

explore

explore

explore